S&P 500   4,443.19 (-0.28%)
DOW   34,926.71 (+0.37%)
QQQ   369.51 (-1.02%)
AAPL   144.88 (-1.39%)
MSFT   294.16 (-1.73%)
FB   351.40 (-0.44%)
GOOGL   2,826.02 (-0.64%)
TSLA   789.74 (+1.98%)
AMZN   3,370.32 (-1.61%)
NVDA   215.42 (-2.44%)
BABA   148.51 (+2.36%)
NIO   36.07 (+1.95%)
CGC   14.68 (+5.54%)
GE   106.03 (+2.15%)
MU   74.96 (+1.23%)
AMD   106.93 (+1.07%)
T   27.61 (+1.77%)
F   14.21 (+3.12%)
ACB   6.29 (+5.71%)
DIS   178.76 (+1.57%)
PFE   43.90 (-0.09%)
BA   226.41 (+2.27%)
BAC   43.21 (+2.54%)
S&P 500   4,443.19 (-0.28%)
DOW   34,926.71 (+0.37%)
QQQ   369.51 (-1.02%)
AAPL   144.88 (-1.39%)
MSFT   294.16 (-1.73%)
FB   351.40 (-0.44%)
GOOGL   2,826.02 (-0.64%)
TSLA   789.74 (+1.98%)
AMZN   3,370.32 (-1.61%)
NVDA   215.42 (-2.44%)
BABA   148.51 (+2.36%)
NIO   36.07 (+1.95%)
CGC   14.68 (+5.54%)
GE   106.03 (+2.15%)
MU   74.96 (+1.23%)
AMD   106.93 (+1.07%)
T   27.61 (+1.77%)
F   14.21 (+3.12%)
ACB   6.29 (+5.71%)
DIS   178.76 (+1.57%)
PFE   43.90 (-0.09%)
BA   226.41 (+2.27%)
BAC   43.21 (+2.54%)
S&P 500   4,443.19 (-0.28%)
DOW   34,926.71 (+0.37%)
QQQ   369.51 (-1.02%)
AAPL   144.88 (-1.39%)
MSFT   294.16 (-1.73%)
FB   351.40 (-0.44%)
GOOGL   2,826.02 (-0.64%)
TSLA   789.74 (+1.98%)
AMZN   3,370.32 (-1.61%)
NVDA   215.42 (-2.44%)
BABA   148.51 (+2.36%)
NIO   36.07 (+1.95%)
CGC   14.68 (+5.54%)
GE   106.03 (+2.15%)
MU   74.96 (+1.23%)
AMD   106.93 (+1.07%)
T   27.61 (+1.77%)
F   14.21 (+3.12%)
ACB   6.29 (+5.71%)
DIS   178.76 (+1.57%)
PFE   43.90 (-0.09%)
BA   226.41 (+2.27%)
BAC   43.21 (+2.54%)
S&P 500   4,443.19 (-0.28%)
DOW   34,926.71 (+0.37%)
QQQ   369.51 (-1.02%)
AAPL   144.88 (-1.39%)
MSFT   294.16 (-1.73%)
FB   351.40 (-0.44%)
GOOGL   2,826.02 (-0.64%)
TSLA   789.74 (+1.98%)
AMZN   3,370.32 (-1.61%)
NVDA   215.42 (-2.44%)
BABA   148.51 (+2.36%)
NIO   36.07 (+1.95%)
CGC   14.68 (+5.54%)
GE   106.03 (+2.15%)
MU   74.96 (+1.23%)
AMD   106.93 (+1.07%)
T   27.61 (+1.77%)
F   14.21 (+3.12%)
ACB   6.29 (+5.71%)
DIS   178.76 (+1.57%)
PFE   43.90 (-0.09%)
BA   226.41 (+2.27%)
BAC   43.21 (+2.54%)
NASDAQ:SLGL

Sol-Gel Technologies Stock Forecast, Price & News

$9.31
-0.03 (-0.32 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.12
$9.50
50-Day Range
$8.85
$12.11
52-Week Range
$7.05
$16.69
Volume16,353 shs
Average Volume43,491 shs
Market Capitalization$189.83 million
P/E RatioN/A
Dividend YieldN/A
Beta1.35
30 days | 90 days | 365 days | Advanced Chart
Receive SLGL News and Ratings via Email

Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter.


Sol-Gel Technologies logo

About Sol-Gel Technologies

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.68 out of 5 stars

Medical Sector

926th out of 1,352 stocks

Pharmaceutical Preparations Industry

459th out of 666 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Sol-Gel Technologies (NASDAQ:SLGL) Frequently Asked Questions

Is Sol-Gel Technologies a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sol-Gel Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Sol-Gel Technologies stock.
View analyst ratings for Sol-Gel Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than Sol-Gel Technologies?

Wall Street analysts have given Sol-Gel Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sol-Gel Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sol-Gel Technologies?

Sol-Gel Technologies saw a decrease in short interest in August. As of August 13th, there was short interest totaling 132,200 shares, a decrease of 12.8% from the July 29th total of 151,600 shares. Based on an average trading volume of 34,400 shares, the days-to-cover ratio is presently 3.8 days. Currently, 1.6% of the shares of the stock are short sold.
View Sol-Gel Technologies' Short Interest
.

When is Sol-Gel Technologies' next earnings date?

Sol-Gel Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for Sol-Gel Technologies
.

How were Sol-Gel Technologies' earnings last quarter?

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) issued its earnings results on Wednesday, August, 4th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by $0.15. The business earned $0.93 million during the quarter, compared to analyst estimates of $3.26 million.
View Sol-Gel Technologies' earnings history
.

How has Sol-Gel Technologies' stock been impacted by Coronavirus (COVID-19)?

Sol-Gel Technologies' stock was trading at $8.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SLGL shares have increased by 12.8% and is now trading at $9.31.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for SLGL?

2 brokerages have issued 1 year price targets for Sol-Gel Technologies' shares. Their forecasts range from $17.00 to $21.00. On average, they anticipate Sol-Gel Technologies' stock price to reach $19.00 in the next year. This suggests a possible upside of 104.1% from the stock's current price.
View analysts' price targets for Sol-Gel Technologies
or view top-rated stocks among Wall Street analysts.

Who are Sol-Gel Technologies' key executives?

Sol-Gel Technologies' management team includes the following people:
  • Alon Seri-Levy, Chief Executive Officer & Director
  • Itzik Yosef, Chief Operating Officer
  • Gilad Mamlok, Chief Financial Officer
  • Ofer Toledano, Vice President-Research & Development
  • Ofra Levy-Hacham, VP-Clinical & Regulatory Affairs

What other stocks do shareholders of Sol-Gel Technologies own?

When did Sol-Gel Technologies IPO?

(SLGL) raised $60 million in an initial public offering on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. ​Jefferies and BMO Capital Markets​ served as the underwriters for the IPO and JMP Securities and Raymond James​ were co-managers.

What is Sol-Gel Technologies' stock symbol?

Sol-Gel Technologies trades on the NASDAQ under the ticker symbol "SLGL."

Who are Sol-Gel Technologies' major shareholders?

Sol-Gel Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Morgan Stanley (0.19%), Morgan Stanley (0.19%), Invesco Ltd. (0.16%) and Citadel Advisors LLC (0.00%).

Which major investors are selling Sol-Gel Technologies stock?

SLGL stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, and Invesco Ltd..

Which major investors are buying Sol-Gel Technologies stock?

SLGL stock was acquired by a variety of institutional investors in the last quarter, including Citadel Advisors LLC.

How do I buy shares of Sol-Gel Technologies?

Shares of SLGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sol-Gel Technologies' stock price today?

One share of SLGL stock can currently be purchased for approximately $9.31.

How much money does Sol-Gel Technologies make?

Sol-Gel Technologies has a market capitalization of $189.83 million and generates $8.77 million in revenue each year. The company earns $-29,290,000.00 in net income (profit) each year or ($1.30) on an earnings per share basis.

How many employees does Sol-Gel Technologies have?

Sol-Gel Technologies employs 65 workers across the globe.

What is Sol-Gel Technologies' official website?

The official website for Sol-Gel Technologies is www.sol-gel.com.

Where are Sol-Gel Technologies' headquarters?

Sol-Gel Technologies is headquartered at 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403648.

How can I contact Sol-Gel Technologies?

Sol-Gel Technologies' mailing address is 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403648. The company can be reached via phone at (728) 931-3433 or via email at [email protected].


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.